Royalty Pharma Reports Third Quarter 2024 Results

Go back to Royalty Pharma Reports Third Quarter 2024 Results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 59.84 +0.39 (0.66%)
Previous Close $59.45    52 Week High $3.48 
Open $59.74    52 Week Low $0.80 
Day High $60.42    P/E N/A 
Day Low $59.73    EPS $-1.54 
Volume 1,102,358